Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

FDA begins consumer transparency initiative

January 13, 2010 Research and Development, Sales and Marketing FDA, transparency

The Food and Drug Administration has unveiled the first phase of its transparency initiative, designed to make its drug approval …
News

Joseph Zakrzewski, executive chairman, Amarin

January 13, 2010 Research and Development Amarin, appointment, research and development

Dublin-headquartered biotech Amarin has appointed Joseph Zakrzewski executive chairman. He is currently the chief executive of Xcellerex, a Massachusetts-based biotechnology …
Appointment

Sanofi Pasteur collaborates on novel biologics

January 12, 2010 Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines

Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …
News

Signs of product payoff from GSK’s $1.5bn alliance

January 12, 2010 Research and Development ChemoCentryx, Crohn's, GlaxoSmithKline

GlaxoSmithKline is to develop and commercialise a drug which hopes will be a treatment for moderate-to-severe Crohn’s disease. Californian biotech …
News
FDA’s Deputy Commissioner for International Programs Murray Lumpkin

Transatlantic conversations

January 11, 2010 Research and Development EMA, FDA

The Pharmafocus interview: Murray Lumpkin, FDA Deputy Commissioner for International ProgramsCollaborations between the world’s leading medicines regulators have increased markedly …
Feature

Michael Moore, chairman, Oxford BioTherapeutics

January 11, 2010 Research and Development Oxford Biotherapeutics, Piramed, appointment, research and development

Oxford BioTherapeutics (OBT) has appointed Dr Michael Moore non-executive chairman. He joins the company following five years spent at UK …
Appointment

Roche signs genetic chemistry technology deal

January 11, 2010 Research and Development Evolva, Roche, genetic chemistry

Roche has signed a deal with Evolva Holding to create anti-infectives and cancer treatments using the latter’s genetic chemistry technology. Roche’s …
News

Alison Clough promoted to commercial and communications director for the ABPI

January 11, 2010 Medical Communications, Research and Development, Sales and Marketing ABPI, appointment, patent box

UK pharma industry association the ABPI has promoted Alison Clough to commercial and communications director. She moves into the new …
Appointment

Marksans presses on with plan to exit API business

January 11, 2010 Manufacturing and Production, Research and Development API, Marksans

India’s Marksans Pharma is seeking approval from its shareholders to divest or lease out its two active pharmaceutical ingredient (API) …
News
Eisai's manufacturing and research facility in South India

Eisai looks to India for API production

January 8, 2010 Manufacturing and Production, Research and Development Eisai, India

Japanese drugmaker Eisai has started operations at a manufacturing and research facility in Visakhapatnam, southern India, which will be the …
News

Stephen Cutler, chief operating officer, Kendle

January 8, 2010 Research and Development Kendle, appointment, research and development

Kendle has appointed Stephen Cutler to the position of senior vice president and chief operating officer.Dr Cutler has a track …
Appointment

AstraZeneca signs deals to increase anti-infective portfolio

January 7, 2010 Research and Development, Sales and Marketing AstraZeneca, Forest, Novexel

AstraZeneca is to buy infection research firm Novexel for $350 million. The manufacturer will take all the French company’s shares …
News
Woodley David

David Wood and Joanne Platt join Woodley Equipment

January 7, 2010 Research and Development appointment, research and development, woodley

Woodley Equipment has appointed David Wood medical electronics manager and Joanne Platt as customer service representative. David will be instrumental …
Appointment

Alcon directors protest Novartis takeover bid

January 6, 2010 Research and Development, Sales and Marketing Alcon, Novartis

An independent committee of directors of Alcon has expressed its disappointment with the recent takeover bid from Novartis, saying the …
News
JGerberding_cdc_photo

Dr Julie Gerberding appointed to head up Merck Vaccines

January 6, 2010 Research and Development, Sales and Marketing Merck, appoinment, research and development, sales and marketing, vaccines

Merck & Co has put a US public health and infectious diseases expert in charge of its $5 billion global …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026